Veeva Systems (VEE) Stock Forecast & Price Target

Compare

8 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

VEE Analyst Ratings

Moderate Buy

16 Buy

6 Hold

1 Sell

Based on 23 analysts giving stock ratings to

Veeva

Systems

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

VEE Stock 12 Month Forecast

Average Price Target

€230.56

▲(46.76% Upside)

Based on 23 Wall Street analysts offering 12 month price targets for Veeva Systems in the last 3 months. The average price target is €230.56 with a high forecast of €294.30 and a low forecast of €164.46. The average price target represents a 46.76% change from the last price of €157.10.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"155":"€155","190":"€190","225":"€225","260":"€260","295":"€295"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":294.3047684,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€294.30</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":230.5618179736,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€230.56</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":164.4644294,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€164.46</span>\n  </div></div>","useHTML":true}}],"tickPositions":[155,190,225,260,295],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,156.15,166.77728987692308,177.40457975384615,188.03186963076922,198.65915950769232,209.28644938461537,219.91373926153847,230.54102913846154,241.1683190153846,251.79560889230768,262.42289876923076,273.05018864615386,283.6774785230769,{"y":294.3047684,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,156.15,161.87398599796924,167.59797199593848,173.3219579939077,179.04594399187692,184.76992998984616,190.4939159878154,196.21790198578464,201.94188798375384,207.66587398172308,213.38985997969232,219.11384597766153,224.83783197563076,{"y":230.5618179736,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,156.15,156.7895714923077,157.4291429846154,158.06871447692308,158.7082859692308,159.34785746153847,159.98742895384615,160.62700044615386,161.26657193846154,161.90614343076922,162.54571492307693,163.1852864153846,163.82485790769232,{"y":164.4644294,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":213.5,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":209.9,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":198.65,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":240.2,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":243.3,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":247.2,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":230,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 48,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":246.8,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 58,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":251.4,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 52,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":208.3,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":192.1,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":172.2,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 57,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":156.15,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 90,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 38, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€294.30

Average Price Target€230.56

Lowest Price Target€164.46

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Stan Berenshteyn

Wells Fargo

€274.4

Buy

74.66%

Upside

Reiterated

03/11/26

Wells Fargo Keeps Their Buy Rating on Veeva Systems (VEEV)

Dylan Becker

William Blair

―

Buy

―

Reiterated

03/10/26

Analysts Are Bullish on These Healthcare Stocks: Tyra Bioscience (TYRA), Veeva Systems (VEEV)

Tyler Radke

Citi

€276.13→€189.57

Buy

20.67%

Upside

Reiterated

03/09/26

Veeva price target lowered to $219 from $319 at CitiVeeva price target lowered to $219 from $319 at Citi

Karl Keirstead

UBS

€173.12→€190.43

Hold

21.22%

Upside

Assigned

03/05/26

Veeva price target raised to $220 from $200 at UBSVeeva price target raised to $220 from $200 at UBS

Kenneth Wong

Oppenheimer

€238.04

Buy

51.52%

Upside

Reiterated

03/05/26

Analysts Are Bullish on These Healthcare Stocks: Viking Therapeutics (VKTX), Xencor (XNCR)

Saket Kalia

Barclays

€216.4

Buy

37.75%

Upside

Reiterated

03/05/26

Analysts Offer Insights on Healthcare Companies: Mediwound (NASDAQ: MDWD) and Veeva Systems (NYSE: VEEV)

Kirk Materne

Evercore ISI

€207.74

Hold

32.24%

Upside

Reiterated

03/05/26

Evercore ISI Sticks to Their Hold Rating for Veeva Systems (VEEV)

Craig Hettenbach

Morgan Stanley

€177.45→€186.1

Hold

18.46%

Upside

Assigned

03/05/26

Strong Near-Term Execution but Uncertain Long-Term Growth Drivers Justify Hold on Veeva

Charles Rhyee

TD Cowen

€328.93→€259.68

Buy

65.30%

Upside

Assigned

03/05/26

Veeva Systems (VEEV) Receives a Buy from TD Cowen

David Grossman

Stifel Nicolaus

€183.51→€212.07

Buy

34.99%

Upside

Assigned

03/05/26

Analysts Are Bullish on These Healthcare Stocks: Veeva Systems (VEEV), Apellis Pharmaceuticals (APLS)

Adam Hotchkiss

Goldman Sachs

€186.1→€164.46

Sell

4.69%

Upside

Reiterated

03/05/26

Veeva price target lowered to $190 from $215 at Goldman SachsVeeva price target lowered to $190 from $215 at Goldman Sachs

Hannah Rudoff

Piper Sandler

€307.29→€246.7

Buy

57.03%

Upside

Reiterated

03/05/26

Piper Sandler Reaffirms Their Buy Rating on Veeva Systems (VEEV)

Sean Dodge

BMO Capital

€190.43

Hold

21.22%

Upside

Reiterated

03/05/26

Analysts Offer Insights on Healthcare Companies: Pulmonx (NASDAQ: LUNG), Veeva Systems (NYSE: VEEV) and Theravance Biopharma (NASDAQ: TBPH)

David Hynes

Canaccord Genuity

€173.12→€203.42

Hold

29.48%

Upside

Reiterated

03/05/26

Veeva price target raised to $235 from $200 at CanaccordVeeva price target raised to $235 from $200 at Canaccord

Jailendra Singh

Truist Financial

€238.04→€226.79

Buy

44.36%

Upside

Reiterated

03/05/26

Truist Financial Remains a Buy on Veeva Systems (VEEV)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Stan Berenshteyn

Wells Fargo

€274.4

Buy

74.66%

Upside

Reiterated

03/11/26

Wells Fargo Keeps Their Buy Rating on Veeva Systems (VEEV)

Dylan Becker

William Blair

―

Buy

―

Reiterated

03/10/26

Analysts Are Bullish on These Healthcare Stocks: Tyra Bioscience (TYRA), Veeva Systems (VEEV)

Tyler Radke

Citi

€276.13→€189.57

Buy

20.67%

Upside

Reiterated

03/09/26

Veeva price target lowered to $219 from $319 at CitiVeeva price target lowered to $219 from $319 at Citi

Karl Keirstead

UBS

€173.12→€190.43

Hold

21.22%

Upside

Assigned

03/05/26

Veeva price target raised to $220 from $200 at UBSVeeva price target raised to $220 from $200 at UBS

Kenneth Wong

Oppenheimer

€238.04

Buy

51.52%

Upside

Reiterated

03/05/26

Analysts Are Bullish on These Healthcare Stocks: Viking Therapeutics (VKTX), Xencor (XNCR)

Saket Kalia

Barclays

€216.4

Buy

37.75%

Upside

Reiterated

03/05/26

Analysts Offer Insights on Healthcare Companies: Mediwound (NASDAQ: MDWD) and Veeva Systems (NYSE: VEEV)

Kirk Materne

Evercore ISI

€207.74

Hold

32.24%

Upside

Reiterated

03/05/26

Evercore ISI Sticks to Their Hold Rating for Veeva Systems (VEEV)

Craig Hettenbach

Morgan Stanley

€177.45→€186.1

Hold

18.46%

Upside

Assigned

03/05/26

Strong Near-Term Execution but Uncertain Long-Term Growth Drivers Justify Hold on Veeva

Charles Rhyee

TD Cowen

€328.93→€259.68

Buy

65.30%

Upside

Assigned

03/05/26

Veeva Systems (VEEV) Receives a Buy from TD Cowen

David Grossman

Stifel Nicolaus

€183.51→€212.07

Buy

34.99%

Upside

Assigned

03/05/26

Analysts Are Bullish on These Healthcare Stocks: Veeva Systems (VEEV), Apellis Pharmaceuticals (APLS)

Adam Hotchkiss

Goldman Sachs

€186.1→€164.46

Sell

4.69%

Upside

Reiterated

03/05/26

Veeva price target lowered to $190 from $215 at Goldman SachsVeeva price target lowered to $190 from $215 at Goldman Sachs

Hannah Rudoff

Piper Sandler

€307.29→€246.7

Buy

57.03%

Upside

Reiterated

03/05/26

Piper Sandler Reaffirms Their Buy Rating on Veeva Systems (VEEV)

Sean Dodge

BMO Capital

€190.43

Hold

21.22%

Upside

Reiterated

03/05/26

Analysts Offer Insights on Healthcare Companies: Pulmonx (NASDAQ: LUNG), Veeva Systems (NYSE: VEEV) and Theravance Biopharma (NASDAQ: TBPH)

David Hynes

Canaccord Genuity

€173.12→€203.42

Hold

29.48%

Upside

Reiterated

03/05/26

Veeva price target raised to $235 from $200 at CanaccordVeeva price target raised to $235 from $200 at Canaccord

Jailendra Singh

Truist Financial

€238.04→€226.79

Buy

44.36%

Upside

Reiterated

03/05/26

Truist Financial Remains a Buy on Veeva Systems (VEEV)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Veeva Systems

3 Months

xxx

Success Rate

23/38 ratings generated profit

Average Return

+4.86%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 60.53% of your transactions generating a profit, with an average return of +4.86% per trade.

1 Year

Kenneth WongOppenheimer

Success Rate

29/47 ratings generated profit

Average Return

+14.65%

reiterated a buy rating 11 days ago

Copying Kenneth Wong's trades and holding each position for 1 Year would result in 61.70% of your transactions generating a profit, with an average return of +14.65% per trade.

2 Years

xxx

Success Rate

12/25 ratings generated profit

Average Return

+1.84%

assigned a xxx

rating 12 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 48.00% of your transactions generating a profit, with an average return of +1.84% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

VEE Analyst Recommendation Trends

Rating

Nov 25

Dec 25

Jan 26

Feb 26

Mar 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

131

In the current month, VEE has received 90 Buy Ratings, 38 Hold Ratings, and 3 Sell Ratings. VEE average Analyst price target in the past 3 months is 230.56.

Each month's total comprises the sum of three months' worth of ratings.

VEE Financial Forecast

VEE Earnings Forecast

Next quarter’s earnings estimate for VEE is €1.86 with a range of €1.83 to €1.91. The previous quarter’s EPS was €1.80. VEE beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year VEE has Performed in-line its overall industry.

VEE Sales Forecast

Next quarter’s sales forecast for VEE is €748.00M with a range of €745.17M to €762.53M. The previous quarter’s sales results were €728.98M. VEE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year VEE has Performed in-line its overall industry.

VEE Stock Forecast FAQ

What is DE:VEE’s average 12-month price target, according to analysts?

Based on analyst ratings, Veeva Systems’s 12-month average price target is 230.56.

What is DE:VEE’s upside potential, based on the analysts’ average price target?

Veeva Systems has 46.76% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Veeva Systems a Buy, Sell or Hold?

Veeva Systems has a consensus rating of Moderate Buy, which is based on 16 buy ratings, 6 hold ratings and 1 sell ratings.

What is Veeva Systems’s share price target?

The average share price target for Veeva Systems is 230.56. This is based on 23 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €294.30 ,and the lowest forecast is €164.46. The average share price target represents 46.76% Increase from the current price of €157.1.

What do analysts say about Veeva Systems?

Veeva Systems’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 23 Wall Streets Analysts.

How can I buy shares of Veeva Systems?

To buy shares of DE:VEE, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Veeva Systems (VEE) Stock Forecast & Price Target

VEE Analyst Ratings

VEE Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Veeva Systems

VEE Analyst Recommendation Trends

VEE Financial Forecast

VEE Earnings Forecast

VEE Sales Forecast

VEE Stock Forecast FAQ

Detailed List of Analyst Forecasts